biostudies-literatureUnknown16Auliac JBastra zeneca<h4>Background</h4>Few epidemiological data are available on surgically treated Caucasian patients with non-small-cell lung cancers (NSCLCs) harboring epidermal growth factor receptor (<i>EGFR</i>) mutations. The main objective of this study was to describe, in the real-world setting, these patients' incidence, clinical, and tumoral characteristics.<h4>Methods</h4>The participating centers included all consecutive localized non-squamous NSCLC patients undergoing surgery between January 2018 and December 2019 in France. <i>EGFR</i> status was determined retrospectively when not available before surgery.<h4>Results</h4>The study includes 1391 no squamous NSCLC patients from 16 centers; <i>EGFR</i> status was determined before surgery in 692 (49.7%) of the cases and conducted as part of the sTherapeutic advances in medical oncology17588359241236451https://www.ebi.ac.uk/biostudies/studies/S-EPMC10919127biostudies-literatureResected <i>EGFR</i>-mutated non-small-cell lung cancers: incidence and outcomes in a European population (GFPC Exerpos Study).PMC10919127Swalduz AThomas PAGuisier FDecroisette CLe Treut JBlons HCurcio HLupo Mansuet ADe Chabot GChouaid CGreillier LBasse VHuchot EAlainVegnenegreBylicki OAuliac JBWislez MMoreau DFalchero LfalseResected <i>EGFR</i>-mutated non-small-cell lung cancers: incidence and outcomes in a European population (GFPC Exerpos Study).<h4>Background</h4>Few epidemiological data are available on surgically treated Caucasian patients with non-small-cell lung cancers (NSCLCs) harboring epidermal growth factor receptor (<i>EGFR</i>) mutations. The main objective of this study was to describe, in the real-world setting, these patients' incidence, clinical, and tumoral characteristics.<h4>Methods</h4>The participating centers included all consecutive localized non-squamous NSCLC patients undergoing surgery between January 2018 and December 2019 in France. <i>EGFR</i> status was determined retrospectively when not available before surgery.<h4>Results</h4>The study includes 1391 no squamous NSCLC patients from 16 centers; <i>EGFR</i> status was determined before surgery in 692 (49.7%) of the cases and conducted as part of the s2024-01-01T00:00:00Z20242025-04-04T12:34:46.486Z2025-04-04T12:34:46.486ZS-EPMC109191273845571110.1177/17588359241236451